Thermo Fisher Scientific Increase Decrease In Operating Capital Excluding Deferred Taxes increased by 969.2% to $1.11B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 22.0%, from $1.43B to $1.11B.
operating_increase_decrease_in_operating_capital_excludi_a48855| Q2 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $126.00M | $875.00M | $849.00M | $367.00M | $1.53B | $718.00M | $9.00M | $787.00M | $216.00M | $1.43B | $726.00M | $104.00M | $1.11B |
| QoQ Change | — | +594.4% | -3.0% | -56.8% | +317.7% | -53.2% | -98.7% | >999% | -72.6% | +559.7% | -49.1% | -85.7% | +969.2% |
| YoY Change | — | — | +573.8% | — | +75.2% | -15.4% | -97.5% | -48.7% | -69.9% | +81.1% | +236.1% | — | -22.0% |